FDAnews Drug Daily Bulletin

SHASUN ACQUIRES CUSTOM SYNTHESIS BUSINESS

April 25, 2006
A A

Shasun Chemicals and Drugs announced that it completed its acquisition of the pharmaceutical custom synthesis business of Rhodia Group. Shasun and Rhodia have confirmed that requirements of due diligence and documentation have been completed. For Shasun Group, it is their first ever acquisition which has been done through its wholly owned subsidiary company, Shasun Pharma Solutions, UK. Express Pharma (http://www.expresspharmaonline.com/20060430/market04.shtml)